FCGR3A polymorphism story: a new piece of the puzzle.
Cartron
Guillaume
G
Department of Hematology, CHU Montpellier, UMR CNRS 5235 Montpellier, France. guillaume.cartron@med.univ-tours.fr
D019943:Amino Acid Substitution / Q000235:genetics / Q000502:physiology; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D054316:Biomarkers, Pharmacological / Q000032:analysis / Q000378:metabolism; D019008:Drug Resistance, Neoplasm / Q000235:genetics / Q000276:immunology; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D020641:Polymorphism, Single Nucleotide / Q000502:physiology; D017452:Receptors, IgG / Q000235:genetics*; D000069283:Rituximab; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology
D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D054316:Biomarkers, Pharmacological; C496124:FCGR3A protein, human; D017452:Receptors, IgG; D000069283:Rituximab